Reena Chokshi, MD
Gastroenterology · Houston, TXNPI 1255494746
Payments from drug & device makers
Across 133 payments — averaging $456.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Enterra Medical, Inc.$46K
- Medtronic$4K
- Ardelyx, Inc.$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- AbbVie$1K
- Conmed Corporation$577
- plus $2K from 23 others
Across 15 payments — averaging $2493.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$37K
What the payments were for
- Consulting fees$5,6259%
- Speaking & faculty fees$42,68870%
- Travel & lodging$2,8705%
- Food & beverage$6,14910%
- Education$3,3896%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Enterra Medical, Inc. | 28 | $46,131 |
| Medtronic | 5 | $4,162 |
| Ardelyx, Inc. | 2 | $3,499 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $2,798 |
| AbbVie(2 entities) | 32 | $1,054 |
| Conmed Corporation | 5 | $577 |
| Laborie Medical Technologies Corp. | 7 | $447 |
| Steris Corporation | 2 | $422 |
| Boston Scientific | 2 | $288 |
| 3-d Matrix, Inc. | 1 | $249 |
| Johnson & Johnson(2 entities) | 3 | $149 |
| Merit Medical Systems Inc | 1 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $113 |
| Dova Pharmaceuticals | 1 | $87 |
| Regeneron Healthcare Solutions, Inc. | 2 | $85 |
| Phathom Pharmaceuticals, Inc. | 1 | $80 |
| Sanofi | 2 | $68 |
| Olympus Corporation Of The Americas | 2 | $61 |
| Endogastric Solutions, Inc | 2 | $59 |
| Abbott | 3 | $54 |
| Merck | 2 | $42 |
| Braintree Laboratories, Inc. | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Alcresta Therapeutics, Inc. | 1 | $25 |
| Romark Laboratories, LC | 1 | $22 |
| Redhill Biopharma Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| QOL Medical, LLC | 1 | $15 |
| Optinose US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IBSRELA$3,499
- XIFAXAN$2,500
- TRUFREEZE$422
- CONMED BILIARY$392
- CONMED GENERATORS$293
- LINZESS$213
- CONMED HEMOSTASIS$167
- ORISE$161
- EndoFlip$147
- GI Genius$135
- WallFlex Duodenal$128
- ESOPHYX$120
- Creon$110
How this compares
$60,720 in reported general payments places this provider in the 85th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 27 | $30,474 |
| TrulancePlecanatide | 11 | $7,362 |
| Dexlansoprazole DrDexlansoprazole | 14 | $3,830 |
| Omeprazole | 73 | $1,334 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 20 | $1,135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,054 | $30,47427 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $2,798 | $7,36211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Houston
- Mazen NoureddinHouston$6.1M
- James MaherHouston$5.3M
- Uma MohanHouston$5M
- John VierlingHouston$2.8M
- Bincy AbrahamHouston$2.5M
- Jason HouHouston$2.3M
- Jignesh ShahHouston$1.7M
- Mouhamad Al-SabbaghHouston$1.6M
- Mohamed OthmanHouston$1.6M
- Harry OjeasHouston$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.